Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • RAWLS Unveils the Exclusive “Beyond Salon” Range in Gurgaon with Jacqueline Fernandez – A New Era of Luxury in India’s Salon Industry Business
  • INHERITCOIN Joins the League of Cryptocurrencies Leveraging Ethereum blockchain Business
  • Spark Minda CEO Neeraj Sharan warns Customers to Beware of Counterfeit Products Business
  • Davangere Sugar Charts Ambitious Expansion Amid India’s Biofuel Push Business
  • Ahmedabad’s Tanvi Rathore won the title of Mrs. Universe Generosity at the 44th Mrs. Universe 2021 held in South Korea Lifestyle
  • IQOO Soul Leave Chennai As Champions Of BGIS 2026 As 6,00,000 Viewers Witness India’s Biggest Ever Mobile Esports Final Sports
  • Greenman Viral Desai celebrates World Life Day at Sarthana Nature Park Press Release
  • Vipin Agnihotri once again win award as Best Emerging Film Director for his movie “Ye Zindganiya” by Dia Mirza Lifestyle

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • British Wellness Brings A New Era in Affordable Healthcare Health
  • What Makes a Health Insurance Plan Worth the Premium? Health
  • Introducing Hidoc Dr KOL Factory The Future Hub for Oncology Leaders Worldwide Health
  • Yogesh Bhateja: Redefining Fitness Excellence with Sonu Sood’s Unprecedented Transformation for Fateh Health
  • Digital Marketer Sociomark Bags Digital Mandate for Ayu Health Health
  • Swasth Hriday Ignites Digital Transformation Dialogue at HEALTHTECH 2025 in Vapi Health

Recent Posts

  • Secretary, Ministry of Ports, Shipping and Waterways Visits New Mangalore Port Authority; Reviews Operations and Launches Key Development Initiatives
  • Yash Raj Films Invests in Rusk Media to Shape the Future of India’s Vertical Entertainment Economy
  • Samsonite Sets a New Standard for Smart Travel with Waypoint™: From luggage maker to travel certainty brand.
  • UnClaimedX Unveils Pass Down to Tackle India’s Silent Inheritance Crisis
  • Acharya Bangalore B School Hosts Startup Garage 2026 to Support the Next Generation of Entrepreneurs

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Team Shabnam: Two Decades of Thoughtful Design Business
  • Murugan G-led Govche India Private Limited launches Comfile360 – A One-Stop Solution for Taxes and Compliances Business
  • The Chronicle Factory Enters a New Era Amid Leadership Shake-Up and Industry Speculation Business
  • VABB- A non-invasive advanced technique to remove benign breast lumps Business
  • USI in collaboration with CSC-e-Governance and PCTI to facilitate the military heritage tourism Business
  • Financepeer and Halp announce strategic partnership to provide end-to-end services for studying abroad Business
  • DevDarshan Overseas: Faith, Fragrance, and a Family Vision Since 1954 Business
  • Shivani Nirupam launches her clothing Label Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme